CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Straumann Holding AG - STMN CFD

139.50
2.2%
Market Trading Hours* (UTC) Opens on Tuesday at 07:00

Mon - Fri: 07:00 - 15:20

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
Trading сonditions
Spread 1.75
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.015001 %
Charges from full value of position ($-2.85)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.015001%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.007221 %
Charges from full value of position ($-1.37)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.007221%
Overnight fee time 21:00 (UTC)
Min traded quantity 0.1
Currency CHF
Margin 5%
Stock exchange Switzerland
Commission on trade 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 136.5
Open* 136.5
1-Year Change* -0.36%
Day's Range* 136.5 - 141.25
52 wk Range 97.00-147.00
Average Volume (10 days) 182.37K
Average Volume (3 months) 5.17M
Market Cap 20.79B
P/E Ratio 55.50
Shares Outstanding 159.36M
Revenue 2.36B
EPS 2.35
Dividend (Yield %) 0.6135
Beta 1.42
Next Earnings Date Feb 19, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Apr 12, 2024 136.50 -5.75 -4.04% 142.25 143.00 136.50
Apr 11, 2024 140.75 1.25 0.90% 139.50 142.50 138.25
Apr 10, 2024 140.25 -3.25 -2.26% 143.50 144.50 136.25
Apr 9, 2024 142.50 3.50 2.52% 139.00 143.00 139.00
Apr 8, 2024 140.25 1.25 0.90% 139.00 141.75 138.75
Apr 5, 2024 139.00 2.25 1.65% 136.75 139.25 136.00
Apr 4, 2024 139.75 -0.25 -0.18% 140.00 140.25 137.50
Apr 3, 2024 139.50 0.50 0.36% 139.00 140.25 137.00
Apr 2, 2024 139.50 -3.25 -2.28% 142.75 142.75 138.25
Mar 28, 2024 142.00 -1.50 -1.05% 143.50 145.00 141.25
Mar 27, 2024 141.75 -2.00 -1.39% 143.75 144.75 141.25
Mar 26, 2024 141.50 3.00 2.17% 138.50 142.50 138.50
Mar 25, 2024 137.50 -3.25 -2.31% 140.75 140.75 136.75
Mar 22, 2024 141.75 -4.00 -2.74% 145.75 146.75 141.00
Mar 21, 2024 145.25 -0.25 -0.17% 145.50 147.75 144.50
Mar 20, 2024 142.50 3.75 2.70% 138.75 143.50 138.75
Mar 19, 2024 139.75 -2.00 -1.41% 141.75 142.50 138.25
Mar 18, 2024 140.25 -3.25 -2.26% 143.50 144.00 140.25
Mar 15, 2024 140.75 -3.50 -2.43% 144.25 145.50 140.75
Mar 14, 2024 144.75 -2.25 -1.53% 147.00 148.25 144.50

Straumann Holding AG Events

Time (UTC) Country Event
Tuesday, April 16, 2024

Time (UTC)

12:00

Country

CH

Event

Straumann Holding AG
Straumann Holding AG

Forecast

-

Previous

-

Time (UTC)

12:00

Country

CH

Event

Straumann Holding AG
Straumann Holding AG

Forecast

-

Previous

-
Thursday, April 18, 2024

Time (UTC)

12:00

Country

CH

Event

Straumann Holding AG
Straumann Holding AG

Forecast

-

Previous

-
Tuesday, April 30, 2024

Time (UTC)

05:00

Country

CH

Event

Q1 2024 Straumann Holding AG Corporate Sales Release
Q1 2024 Straumann Holding AG Corporate Sales Release

Forecast

-

Previous

-
Tuesday, June 4, 2024

Time (UTC)

10:59

Country

CH

Event

Straumann Holding AG at Exane BNPP CEO Conference
Straumann Holding AG at Exane BNPP CEO Conference

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 2320.78 2021.9 1425.85 1596.22 1363.56
Revenue 2320.78 2021.9 1425.85 1596.22 1363.56
Cost of Revenue, Total 564.746 481.88 387.544 391.477 335.315
Gross Profit 1756.04 1540.02 1038.31 1204.75 1028.24
Total Operating Expense 1785.44 1480.2 1279.91 1202.98 1017.52
Selling/General/Admin. Expenses, Total 1158.47 992.898 718.686 797.848 680.034
Unusual Expense (Income) 13.751 -0.38 166.416 18.715 5.59
Other Operating Expenses, Total -4.856 -4.813 -4.592 -5.063 -3.424
Operating Income 535.35 541.701 145.942 393.248 346.045
Interest Income (Expense), Net Non-Operating -36.75 -64.224 -31.899 -27.357 -19.343
Other, Net -0.165 -0.092 -0.136 -0.422 -0.276
Net Income Before Taxes 498.435 477.385 113.907 365.469 326.426
Net Income After Taxes 434.78 399.286 92.267 308.029 277.787
Minority Interest 0.009 -3.206 -0.986 -1.556 -5.017
Net Income Before Extra. Items 434.789 396.08 91.281 306.473 272.77
Net Income 434.789 396.08 91.281 306.473 272.77
Total Adjustments to Net Income -0.001 0.001
Income Available to Common Excl. Extra. Items 434.789 396.079 91.282 306.473 272.77
Income Available to Common Incl. Extra. Items 434.789 396.079 91.282 306.473 272.77
Diluted Net Income 434.789 396.079 91.282 306.473 272.77
Diluted Weighted Average Shares 159.572 159.592 159.248 159.136 158.809
Diluted EPS Excluding Extraordinary Items 2.72473 2.48182 0.57321 1.92585 1.7176
Dividends per Share - Common Stock Primary Issue 0.8 0.675 0.575 0.575 0.525
Diluted Normalized EPS 2.82064 2.51461 2.27359 2.02497 1.74755
Depreciation / Amortization 53.321 10.617 11.855
Jun 2023 Dec 2022 Jun 2022
Total revenue 1216.89 1142.45 1178.34
Revenue 1216.89 1142.45 1178.34
Cost of Revenue, Total 301.636 283.372 282.677
Gross Profit 915.252 859.074 895.662
Total Operating Expense 920.304 930.992 854.443
Selling/General/Admin. Expenses, Total 602.445 650.773 573.469
Other Operating Expenses, Total -3.873 -3.153 -1.703
Operating Income 296.584 211.454 323.896
Interest Income (Expense), Net Non-Operating -41.091 -28.708 -8.207
Net Income Before Taxes 255.493 182.746 315.689
Net Income After Taxes 209.615 169.514 265.266
Minority Interest -0.243 -0.128 0.137
Net Income Before Extra. Items 209.372 169.386 265.403
Net Income 205.776 169.386 265.403
Income Available to Common Excl. Extra. Items 209.372 169.386 265.403
Income Available to Common Incl. Extra. Items 205.776 169.386 265.403
Diluted Net Income 205.776 169.386 265.403
Diluted Weighted Average Shares 159.627 159.705 159.881
Diluted EPS Excluding Extraordinary Items 1.31163 1.06062 1.66
Dividends per Share - Common Stock Primary Issue 0 0.8 0
Diluted Normalized EPS 1.39329 1.06062 1.66
Depreciation / Amortization 4.208
Unusual Expense (Income) 15.888
Total Extraordinary Items -3.596
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 1593.21 1528.67 1152.25 881.665 765.031
Cash and Short Term Investments 696.102 880.423 632.201 260.211 278.674
Cash 381.133 743.669 508.713 249.673 268.252
Short Term Investments 314.969 136.754 123.488 10.539 10.422
Total Receivables, Net 570.123 393.806 301.183 380.961 300.286
Accounts Receivable - Trade, Net 416.366 287.269 236.027 281.21 231.301
Total Inventory 321.172 249.227 216.57 234.553 182.053
Prepaid Expenses 4.808 4.141 2.009 4.361 2.939
Other Current Assets, Total 1.01 1.075 0.289 1.579 1.079
Total Assets 3373.44 2968.04 2548.61 2389.98 1864.57
Property/Plant/Equipment, Total - Net 663.493 578.87 549.131 575.748 230.206
Property/Plant/Equipment, Total - Gross 1191.07 1044.49 977.781 953.788 568.038
Accumulated Depreciation, Total -527.58 -465.62 -428.65 -378.039 -337.831
Goodwill, Net 524.311 425.35 424.258 484.628 417.286
Intangibles, Net 253.639 213.537 226.027 258.213 235.157
Long Term Investments 207.29 119.486 103.528 100.701 119.515
Note Receivable - Long Term 25.685 25.297 17.415 28.68 26.957
Other Long Term Assets, Total 105.802 76.826 76.002 60.343 70.417
Total Current Liabilities 972.104 562.628 379.42 578.983 274.35
Accounts Payable 83.229 74.832 49.919 63.207 47.557
Accrued Expenses 173.882 160.273 105.171 136.778 94.178
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 306.608 25.846 25.934 223.859 0.72
Other Current Liabilities, Total 408.386 301.678 198.396 155.139 131.896
Total Liabilities 1521.84 1472.64 1343.88 1026.56 663.645
Total Long Term Debt 394.988 680.723 696.113 231.642 201.191
Long Term Debt 199.901 479.841 479.726 0 199.862
Capital Lease Obligations 195.087 200.882 216.387 231.642 1.329
Deferred Income Tax 52.696 31.04 43.228 36.887 36.211
Minority Interest 2.247 5.048 5.209 3.809 3.396
Other Liabilities, Total 99.802 193.199 219.909 175.244 148.497
Total Equity 1851.6 1495.4 1204.73 1363.41 1200.92
Common Stock 1.595 1.592 1.591 1.588 1.588
Additional Paid-In Capital 102.012 70.567 52.599 31.412 31.412
Retained Earnings (Accumulated Deficit) 2223.18 1843.82 1536.49 1556.27 1356.84
Treasury Stock - Common -11.08 -5.462 -11.07 -9.361 -19.87
Other Equity, Total -464.107 -415.118 -374.876 -216.498 -169.045
Total Liabilities & Shareholders’ Equity 3373.44 2968.04 2548.61 2389.98 1864.57
Total Common Shares Outstanding 159.355 159.157 158.92 158.655 158.334
Payable/Accrued -0.001 -0.001 -0.001
Cash & Equivalents -0.001
Jun 2023 Dec 2022 Jun 2022
Total Current Assets 1588.46 1593.21 1544.73
Cash and Short Term Investments 606.157 698.961 737.649
Cash & Equivalents 603.125 696.103 734.801
Short Term Investments 3.032 2.858 2.848
Total Receivables, Net 622.483 573.082 510.712
Accounts Receivable - Trade, Net 594.01 544.842 495.182
Total Inventory 359.819 321.172 296.371
Other Current Assets, Total 0.001
Total Assets 3425.2 3373.44 3186.72
Property/Plant/Equipment, Total - Net 684.114 663.493 637.657
Intangibles, Net 815.94 777.95 701.761
Long Term Investments 198.786 212.475 185.528
Note Receivable - Long Term 25.295 21.402 17.491
Other Long Term Assets, Total 112.605 104.9 99.553
Total Current Liabilities 956.043 972.104 543.636
Payable/Accrued 568.276 574.107 449.707
Notes Payable/Short Term Debt 0 0 0
Current Port. of LT Debt/Capital Leases 306.839 307.198 28.641
Other Current Liabilities, Total 80.928 90.799 65.288
Total Liabilities 1531.18 1521.84 1438.84
Total Long Term Debt 399.851 403.117 696.764
Long Term Debt 399.851 403.117 696.764
Deferred Income Tax 48.284 52.696 59.532
Minority Interest 2.158 2.247 2.35
Other Liabilities, Total 124.845 91.673 136.554
Total Equity 1894.02 1851.6 1747.89
Common Stock 1.595 1.595 1.594
Additional Paid-In Capital 102.012 102.012 102.012
Retained Earnings (Accumulated Deficit) 2283.48 2223.18 2050.01
Treasury Stock - Common -13.929 -11.08 -7.93
Other Equity, Total -479.141 -464.107 -397.798
Total Liabilities & Shareholders’ Equity 3425.2 3373.44 3186.72
Total Common Shares Outstanding 159.355 159.355 159.157

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Straumann Company profile

About Straumann Holding AG

Straumann Holding AG is a Switzerland-based company active in the field of implant and restorative dentistry and oral tissue regeneration. In collaboration with clinics, research institutes and universities, the Group researches and develops implants, instruments, computer-aided design/manufacturing (CAD/CAM) prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann Holding AG also offers a range of services to the dental profession worldwide, including training and education, provided in collaboration with the International Team for Implantology (ITI). Its products and services are available in a number of countries through the Group’s headquarters and through a network of subsidiaries and technology partners located in Europe, North America, the Asia/Pacific region and in Latin America, including Dental Wings Inc based in Canada and Createch Medical SL based in Spain.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Straumann Holding AG revenues increased 42% to SF2.02B. Net income applicable to common stockholders increased from SF91.3M to SF396.1M. Revenues reflect Sales NAM segment increase of 39% to SF613.6M, Sales APAC segment increase of 39% to SF388.8M, Sales LATAM segment increase of 44% to SF129.7M, Others segment increase of 35% to SF666.9M, United States segment increase of 30% to SF516.9M.

Industry: Medical Prosthetics

Peter Merian-Weg 12
BASEL
BASEL-STADT 4002
CH

Income Statement

  • Annual
  • Quarterly

News

US Earnings Season : JP Morgan, Citigroup, Wells Fargo

The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

16:03, 11 April 2024

Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues

The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

09:22, 11 April 2024

US CPI Preview: US inflation expected to grind lower amid fears about sticky prices

US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).

15:11, 9 April 2024

How escalating geopolitical tensions are impacting oil markets

The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.

13:34, 4 April 2024

A way forward: a roundup of recent central bank decisions

Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.

12:47, 22 March 2024

Bank of Japan Preview: will the BOJ end negative interest rates?

The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

08:44, 18 March 2024

Higher CPI leaves traders unfazed as US equities continue to build momentum

The latest US CPI reading hasn’t gone how the Federal would have hoped. Consumer prices came in higher than expected in February for the third month in a row.

12:42, 15 March 2024

People also watch

US100

18,045.30 Price
+0.020% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 1.8

Gold

2,347.22 Price
+0.200% 1D Chg, %
Long position overnight fee -0.0191%
Short position overnight fee 0.0109%
Overnight fee time 21:00 (UTC)
Spread 0.50

BTC/USD

64,621.05 Price
+1.230% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

XRP/USD

0.50 Price
+2.250% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

Still looking for a broker you can trust?

Join the 610,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading